Acute Provoked Seizures—Work-Up and Management in Adults

Abstract

Acute provoked seizures, also known as acute symptomatic seizures, occur secondary to a neurological or systemic precipitant, commonly presenting as a first-time seizure. In this article, we will discuss etiology, emergent protocols, medical work-up, initial treatment, and management of these seizures. The definitions, classifications, and management of convulsive status epilepticus and nonconvulsive status epilepticus in an acute setting will also be reviewed.

Keywords

acute provoked seizures - acute symptomatic seizures - nonconvulsive seizures - convulsive status epilepticus

Publikationsverlauf

Artikel online veröffentlicht:
05. November 2020

• References

• 1 Beleza P. Acute symptomatic seizures: a clinically oriented review. Neurologist 2012; 18 (03) 109-119
• 2 Beghi E, Carpio A, Forsgren L. et al. Recommendation for a definition of acute symptomatic seizure. Epilepsia 2010; 51 (04) 671-675
• 3 Karceski S. Acute symptomatic seizures and systemic illness. Continuum (Minneap Minn) 2014; 20 (3 Neurology of Systemic Disease): 614-623
• 4 Fisher RS, Cross JH, French JA. et al. Operational classification of seizure types by the International League Against Epilepsy: position paper of the ILAE Commission for Classification and Terminology. Epilepsia 2017; 58 (04) 522-530
• 5 Husain AM, Horn GJ, Jacobson MP. Non-convulsive status epilepticus: usefulness of clinical features in selecting patients for urgent EEG. J Neurol Neurosurg Psychiatry 2003; 74 (02) 189-191
• 6 Chong DJ, Hirsch LJ. Which EEG patterns warrant treatment in the critically ill? Reviewing the evidence for treatment of periodic epileptiform discharges and related patterns. J Clin Neurophysiol 2005; 22 (02) 79-91
• 7 Brophy GM, Bell R, Claassen J. Neurocritical Care Society Status Epilepticus Guideline Writing Committee. et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 2012; 17 (01) 3-23
• 8 Trinka E, Cock H, Hesdorffer D. et al. A definition and classification of status epilepticus--Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia 2015; 56 (10) 1515-1523
• 9 Nelson SE, Varelas PN. Status epilepticus, refractory status epilepticus, and super-refractory status epilepticus. Continuum (Minneap Minn) 2018; 24 (06) 1683-1707
• 10 Beniczky S, Hirsch LJ, Kaplan PW. et al. Unified EEG terminology and criteria for nonconvulsive status epilepticus. Epilepsia 2013; 54 (Suppl. 06) 28-29
• 11 Annegers JF, Hauser WA, Lee JR-J, Rocca WA. Incidence of acute symptomatic seizures in Rochester, Minnesota, 1935-1984. Epilepsia 1995; 36 (04) 327-333
• 12 Hesdorffer DC, D'Amelio M. Mortality in the first 30 days following incident acute symptomatic seizures. Epilepsia 2005; 46 (Suppl. 11) 43-45
• 13 Hesdorffer DC, Benn EKT, Cascino GD, Hauser WA. Is a first acute symptomatic seizure epilepsy? Mortality and risk for recurrent seizure. Epilepsia 2009; 50 (05) 1102-1108
• 14 Holmquist L. Hospitalizations for Epilepsy and Convulsions, 2005. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs #46 [Internet]. 2008 . Available at: https://www.ncbi.nlm.nih.gov/books/NBK56315/. Accessed September 4, 2019
• 15 Fields MC, Labovitz DL, French JA. Hospital-onset seizures: an inpatient study. JAMA Neurol 2013; 70 (03) 360-364
• 16 Oddo M, Carrera E, Claassen J, Mayer SA, Hirsch LJ. Continuous electroencephalography in the medical intensive care unit. Crit Care Med 2009; 37 (06) 2051-2056
• 17 Claassen J, Mayer SA, Kowalski RG, Emerson RG, Hirsch LJ. Detection of electrographic seizures with continuous EEG monitoring in critically ill patients. Neurology 2004; 62 (10) 1743-1748
• 18 Wasim M, Husain AM. Nonconvulsive seizure control in the intensive care unit. Curr Treat Options Neurol 2015; 17 (03) 340
• 19 Zehtabchi S, Abdel Baki SG, Malhotra S, Grant AC. Nonconvulsive seizures in patients presenting with altered mental status: an evidence-based review. Epilepsy Behav 2011; 22 (02) 139-143
• 20 Naeije G, Depondt C, Meeus C, Korpak K, Pepersack T, Legros B. EEG patterns compatible with nonconvulsive status epilepticus are common in elderly patients with delirium: a prospective study with continuous EEG monitoring. Epilepsy Behav 2014; 36: 18-21
• 21 Jette N, Claassen J, Emerson RG, Hirsch LJ. Frequency and predictors of nonconvulsive seizures during continuous electroencephalographic monitoring in critically ill children. Arch Neurol 2006; 63 (12) 1750-1755
• 22 Friedman D, Claassen J, Hirsch LJ. Continuous electroencephalogram monitoring in the intensive care unit. Anesth Analg 2009; 109 (02) 506-523
• 23 Camilo O, Goldstein LB. Seizures and epilepsy after ischemic stroke. Stroke 2004; 35 (07) 1769-1775
• 24 Beghi E, D'Alessandro R, Beretta S. Epistroke Group. et al. Incidence and predictors of acute symptomatic seizures after stroke. Neurology 2011; 77 (20) 1785-1793
• 25 Gunawardane N, Fields M. Acute symptomatic seizures and provoked seizures: to treat or not to treat?. Curr Treat Options Neurol 2018; 20 (10) 41
• 26 McLauchlan DJ, Powell R. Acute symptomatic seizures. Pract Neurol 2012; 12 (03) 154-165
• 27 Bladin CF, Alexandrov AV, Bellavance A. et al. Seizures after stroke: a prospective multicenter study. Arch Neurol 2000; 57 (11) 1617-1622
• 28 Claassen J, Peery S, Kreiter KT. et al. Predictors and clinical impact of epilepsy after subarachnoid hemorrhage. Neurology 2003; 60 (02) 208-214
• 29 Dastur CK, Yu W. Current management of spontaneous intracerebral haemorrhage. Stroke Vasc Neurol 2017; 2 (01) 21-29
• 30 Won S-Y, Konczalla J, Dubinski D. et al. A systematic review of epileptic seizures in adults with subdural haematomas. Seizure 2017; 45: 28-35
• 31 Hillbom M, Pieninkeroinen I, Leone M. Seizures in alcohol-dependent patients: epidemiology, pathophysiology and management. CNS Drugs 2003; 17 (14) 1013-1030
• 32 Nwani PO, Nwosu MC, Nwosu MN. Epidemiology of acute symptomatic seizures among adult medical admissions. Epilepsy Res Treat 2016; 2016: 4718372
• 33 Kim MA, Park KM, Kim SE, Oh MK. Acute symptomatic seizures in CNS infection. Eur J Neurol 2008; 15 (01) 38-41
• 34 Zoons E, Weisfelt M, de Gans J. et al. Seizures in adults with bacterial meningitis. Neurology 2008; 70 (22) (Pt 2): 2109-2115
• 35 Rosman NP, Peterson DB, Kaye EM, Colton T. Seizures in bacterial meningitis: prevalence, patterns, pathogenesis, and prognosis. Pediatr Neurol 1985; 1 (05) 278-285
• 36 Annegers JF, Hauser WA, Beghi E, Nicolosi A, Kurland LT. The risk of unprovoked seizures after encephalitis and meningitis. Neurology 1988; 38 (09) 1407-1410
• 37 Singhi P. Neurocysticercosis. Ther Adv Neurol Disord 2011; 4 (02) 67-81
• 38 Joseph FG, Scolding NJ. Cerebral vasculitis: a practical approach. Pract Neurol 2002; 2 (02) 80-93
• 39 Dalmau J, Gleichman AJ, Hughes EG. et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008; 7 (12) 1091-1098
• 40 Riggs JE. Neurologic manifestations of electrolyte disturbances. Neurol Clin 2002; 20 (01) 227-239 , vii
• 41 Glauser T, Shinnar S, Gloss D. et al. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the Guideline Committee of the American Epilepsy Society. Epilepsy Curr 2016; 16 (01) 48-61
• 42 Claassen J, Goldstein JN. Emergency neurological life support: status epilepticus. Neurocrit Care 2017; 27 (Suppl. 01) 152-158
• 43 Litt B, Wityk RJ, Hertz SH. et al. Nonconvulsive status epilepticus in the critically ill elderly. Epilepsia 1998; 39 (11) 1194-1202
• 44 Abend NS, Dlugos DJ, Hahn CD, Hirsch LJ, Herman ST. Use of EEG monitoring and management of non-convulsive seizures in critically ill patients: a survey of neurologists. Neurocrit Care 2010; 12 (03) 382-389
• 45 Kowalski RG, Ziai WC, Rees RN. et al. Third-line antiepileptic therapy and outcome in status epilepticus: the impact of vasopressor use and prolonged mechanical ventilation. Crit Care Med 2012; 40 (09) 2677-2684
• 46 Sutter R, Marsch S, Fuhr P, Kaplan PW, Rüegg S. Anesthetic drugs in status epilepticus: risk or rescue? A 6-year cohort study. Neurology 2014; 82 (08) 656-664
• 47 Alvarez V, Lee JW, Westover MB. et al. Therapeutic coma for status epilepticus: differing practices in a prospective multicenter study. Neurology 2016; 87 (16) 1650-1659
• 48 Mayer SA, Claassen J, Lokin J, Mendelsohn F, Dennis LJ, Fitzsimmons BF. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol 2002; 59 (02) 205-210
• 49 Treiman DM, Meyers PD, Walton NY. Veterans Affairs Status Epilepticus Cooperative Study Group. et al. A comparison of four treatments for generalized convulsive status epilepticus. N Engl J Med 1998; 339 (12) 792-798
• 50 Alldredge BK, Gelb AM, Isaacs SM. et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med 2001; 345 (09) 631-637
• 51 Rao SK, Mahulikar A, Ibrahim M, Shah A, Seraji-Bozorgzad N, Mohamed W. Inadequate benzodiazepine dosing may result in progression to refractory and non-convulsive status epilepticus. Epileptic Disord 2018; 20 (04) 265-269
• 52 Silbergleit R, Durkalski V, Lowenstein D. NETT Investigators. et al. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med 2012; 366 (07) 591-600
• 53 Husain AM, Lee JW, Kolls BJ. Critical Care EEG Monitoring Research Consortium. et al. Randomized trial of lacosamide versus fosphenytoin for nonconvulsive seizures. Ann Neurol 2018; 83 (06) 1174-1185
• 54 Brigo F, Del Giovane C, Nardone R, Trinka E, Lattanzi S. Intravenous antiepileptic drugs in adults with benzodiazepine-resistant convulsive status epilepticus: A systematic review and network meta-analysis. Epilepsy Behav 2019; 101 (Pt B): 106466
• 55 French JA, Gazzola DM. Antiepileptic drug treatment: new drugs and new strategies. Continuum (Minneap Minn) 2013; 19 (3 Epilepsy): 643-655
• 56 Yasiry Z, Shorvon SD. The relative effectiveness of five antiepileptic drugs in treatment of benzodiazepine-resistant convulsive status epilepticus: a meta-analysis of published studies. Seizure 2014; 23 (03) 167-174
• 57 Falip M, Carreño M, Amaro S. et al. Use of levetiracetam in hospitalized patients. Epilepsia 2006; 47 (12) 2186-2188
• 58 Höfler J, Trinka E. Lacosamide as a new treatment option in status epilepticus. Epilepsia 2013; 54 (03) 393-404
• 59 Abou-Khalil BW. Update on antiepileptic drugs 2019. Continuum (Minneap Minn) 2019; 25 (02) 508-536
• 60 Hocker S, Clark S, Britton J. Parenteral phenobarbital in status epilepticus revisited: Mayo Clinic experience. Epilepsia 2018; 59 (Suppl. 02) 193-197
• 61 Ho C-J, Lin C-H, Lu Y-T. et al. Perampanel treatment for refractory status epilepticus in a neurological intensive care unit. Neurocrit Care 2019; 31 (01) 24-29
• 62 Leo A, Giovannini G, Russo E, Meletti S. The role of AMPA receptors and their antagonists in status epilepticus. Epilepsia 2018; 59 (06) 1098-1108
• 63 Klein P, Schiemann J, Sperling MR. et al. A randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial-onset seizures. Epilepsia 2015; 56 (12) 1890-1898
• 64 Farrokh S, Bon J, Erdman M, Tesoro E. Use of newer anticonvulsants for the treatment of status epilepticus. Pharmacotherapy 2019; 39 (03) 297-316
• 65 Ng Y-T, Collins SD. Clobazam. Neurotherapeutics 2007; 4 (01) 138-144